US 11053495
Multi-targeted single entity conjugates
granted A61KA61K47/549A61K47/55
Quick answer
US patent 11053495 (Multi-targeted single entity conjugates) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K47/549, A61K47/55